| Lundbeck (Schweiz) AG - Vyepti 100 mg/1 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 67995 | | 01 | | Vyepti 100 mg/1 ml | | Konzentrat zur Herstellung einer Infusionslösung | | N02CD05 | | Eptinezumab | | 11.10.2021 | | |
|
| Composition |
| eptinezumabum 100 mg, histidinum, histidini hydrochloridum monohydricum, sorbitolum 40.5 mg, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Eptinezumabum | 100 mg/ml |
| | BAG: Active Agent | Dose |
|---|
| Eptinezumabum | 100 mg |
| | | | Inactive agents | Dose |
|---|
| Histidin Hydrochloride Monohydrate | | | Histidine | | | Polysorbatum 80 | | | Sorbitol | 40.5 mg/ml |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 1 ml | 1141.21 | 1257.55 | B | SL | No |
|
